Cutera gets FDA warning letter over a website promoting a device for vaginal procedures

Dec. 01, 2022 5:16 PM ETCutera, Inc. (CUTR)By: Anuron Mitra, SA News Editor

FDA Headquarters - White Oak Campus


  • Cutera (NASDAQ:CUTR) on Thursday said it had recently been issued a warning letter from the U.S. FDA regarding marketing material over a device that the company stopped promoting in 2019.
  • CUTR in 2019 had made commitments to the

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.